We measured multiple omics data, such as transcriptomics, proteomics, and metabolomics, of GBM cells cultured with and without Orexin A, and identified differentially expressed molecules that were significantly altered in each omics layer in orexin-added GBM cells relative to those without OXA, and linked these layers to differential regulation. The gene discussed is HCRT; the disease is glioblastoma.